ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data

Toronto, Ontario--(. - July 6, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven Alzhe